Search our Database of Scientific Publications and Authors

I’m looking for a

    1292 results match your criteria Amyloidosis Primary Systemic

    1 OF 26

    A case of amyloid myopathy diagnosed during the treatment of myopathy associated with anti-signal recognition particle antibodies.
    Rinsho Shinkeigaku 2017 Mar 30. Epub 2017 Mar 30.
    Department of Neurology, Shizuoka General Hospital.
    A 78-year-old man presented with subacute progressive proximal weakness and dysphagia. A biopsy specimen from the left biceps femoris revealed evidence of necrotic and regenerating muscle fibers, but lymphocyte infiltration was not noted. The patient was diagnosed with necrotizing myopathy with anti-signal recognition particle (SRP) antibodies. Read More

    Primary Localized Cutaneous Amyloidosis: A Systematic Treatment Review.
    Am J Clin Dermatol 2017 Mar 24. Epub 2017 Mar 24.
    Department of Dermatology, University Hospital Jena, Erfurter Straße 35, Jena, 07743, Germany.
    Background: Primary localized cutaneous amyloidosis (PLCA) is characterized by extracellular deposition of heterogenic amyloid proteins in the skin without systemic involvement. Lichen amyloidosis, macular amyloidosis, and (primary localized cutaneous) nodular amyloidosis are different subtypes of PLCA.

    Objective: The aim of this study was to review the current reported treatment options for PLCA. Read More

    Total Artificial Heart Implantation as a Bridge to Heart Transplantation in an Active Duty Service Member With Amyloid Cardiomyopathy.
    Mil Med 2017 Mar;182(3):e1858-e1860
    Cedars-Sinai Medical Center, Heart Institute, 127 South San Vincente Boulevard, Los Angeles, CA 90048.
    Introduction: Cardiac involvement by light-chain (AL) amyloid occurs in up to 50% of patients with primary AL amyloidosis. The prognosis of amyloid heart disease is poor with 1-year survival rates of 35 to 40%. Historically, heart transplantation was considered controversial for patients with AL amyloid cardiomyopathy (CM) given the systemic nature of the disease and poor survival. Read More

    Primary Hepatic Amyloidosis Presenting as Acute-on-Chronic Liver Failure.
    ACG Case Rep J 2017 15;4:e22. Epub 2017 Feb 15.
    Department of Hepatology, Institute of Liver and Biliary Sciences, Vasant Kunj, New Delhi, India.
    Systemic amyloidosis of amyloid light chain associated protein (AL), also called primary amyloidosis, frequently involves the liver, but rarely causes clinically apparent liver disease. The more common presentation is with acute renal failure. Hepatomegaly and mild elevation of alkaline phosphatase are the most common clinical and biochemical findings, respectively. Read More

    Relapsing bullous amyloidosis of the oral mucosa and acquired cutis laxa in a patient with multiple myeloma: a rare triple association.
    Clin Exp Dermatol 2017 Mar 1. Epub 2017 Mar 1.
    Department of Dermatology, Hospital Universitario La Paz, Madrid, Spain.
    It is well known that primary systemic amyloidosis [light chain (AL) amyloidosis] is associated with hidden dyscrasia or multiple myeloma. Acquired cutis laxa (cutis laxa acquisita; CLA) has also been described in patients with plasma cell dyscrasias, including multiple myeloma. We report a case in which haemorrhagic oral bullae were the first sign of an undiagnosed primary systemic amyloidosis related to multiple myeloma IgG-λ and previously diagnosed CLA. Read More

    Amyloid cardiomyopathy.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2017 Feb 1. Epub 2017 Feb 1.
    Department of Hemato-Oncology, University Hospital Olomouc, Czech Republic.
    Amyloidosis is a heterogeneous group of diseases characterized by the deposition of amyloid. It is caused by extracellular deposition of insoluble fibrils with beta-pleated sheet configuration. The protein misfolding abnormalities result in amyloid fibrils and may manifest as primary, secondary, or familial amyloidosis. Read More

    Amyloidosis of the Lung.
    Arch Pathol Lab Med 2017 Feb;141(2):247-254
    Context: -Amyloidosis is a heterogeneous group of diseases characterized by the deposition of congophilic amyloid fibrils in the extracellular matrix of tissues and organs. To date, 31 fibril proteins have been identified in humans, and it is now recommended that amyloidoses be named after these fibril proteins. Based on this classification scheme, the most common forms of amyloidosis include systemic AL (formerly primary), systemic AA (formerly secondary), systemic wild-type ATTR (formerly age-related or senile systemic), and systemic hereditary ATTR amyloidosis (formerly familial amyloid polyneuropathy). Read More

    The amyloidogenic light chain is a stressor that sensitizes plasma cells to proteasome inhibitor toxicity.
    Blood 2017 Apr 27;129(15):2132-2142. Epub 2017 Jan 27.
    Unit of Age Related Diseases, Division of Genetics and Cell Biology.
    Systemic light chain (AL) amyloidosis is caused by the clonal production of an unstable immunoglobulin light chain (LC), which affects organ function systemically. Although pathogenic LCs have been characterized biochemically, little is known about the biology of amyloidogenic plasma cells (PCs). Intrigued by the unique response rates of AL amyloidosis patients to the first-in-class proteasome inhibitor (PI) bortezomib, we purified and investigated patient-derived AL PCs, in comparison with primary multiple myeloma (MM) PCs, the prototypical PI-responsive cells. Read More

    Isolated primary amyloidosis of the inferior rectus muscle mimicking Graves' orbitopathy.
    Einstein (Sao Paulo) 2016 Oct-Dec;14(4):553-556
    Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.
    The diagnosis of Graves' orbitopathy is usually straightforward. However, orbital diseases that mimick some clinical signs of Graves' orbitopathy may cause diagnostic confusion, particularly when associated to some form of thyroid dysfunction. This report describes the rare occurrence of localized inferior rectus muscle amyloidosis in a patient with autoimmune hypothyroidism, who was misdiagnosed as Graves' orbitopathy. Read More

    Lung adenocarcinoma expressing receptor for advanced glycation end-products with primary systemic AL amyloidosis: a case report and literature review.
    BMC Cancer 2017 Jan 5;17(1):22. Epub 2017 Jan 5.
    Department of Respiratory Medicine, Juntendo University School of Medicine & Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
    Background: Receptor for advanced glycation end-products (RAGE), a receptor for amyloids, is constitutively expressed in lungs and generally observed to be downregulated in lung cancer tissues. However, increasing levels of RAGE or serum amyloids is associated with poor outcome in lung cancer patients. We report a rare case of primary systemic amyloid light-chain (AL) amyloidosis in biopsy-proven multiple organs with early-stage non-small cell lung cancer (NSCLC) that displayed strong staining for RAGE in the tumour tissue. Read More

    Coexistence of amyloidosis and Primary Sjögren's Syndrome: An overview Amyloidosis and Sjögren's syndrome.
    Curr Rheumatol Rev 2017 Jan 3. Epub 2017 Jan 3.
    Immunology and Rheumatology Department. Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán. Vasco de Quiroga 15, Col. Belisario Dominguez Sección XVI. CP 14080.Mexico City, Mexico.
    Background: The association of primary Sjögren´s syndrome (SS) and amyloidosis has been recognized but scarcely assessed.

    Objective: Herein we analyzed the literature regarding this association in order to describe a SS phenotype prone to both conditions.

    Methods: PubMed and CINAHL databases were searched from inception until April 2016 for the key words: amyloidosis, amyloid, Sjögren's syndrome and their combinations. Read More

    Anterior Aortic Plane Systolic Excursion: A Novel Indicator of Transplant-Free Survival in Systemic Light-Chain Amyloidosis.
    J Am Soc Echocardiogr 2016 Dec 27;29(12):1188-1196. Epub 2016 Oct 27.
    Department of Cardiology, University of Heidelberg, Heidelberg, Germany.
    Background: Anterior aortic plane systolic excursion (AAPSE) was evaluated in the present pilot study as a novel echocardiographic indicator of transplant-free survival in patients with systemic light-chain amyloidosis.

    Methods: Eighty-nine patients with light-chain amyloidosis were included in the post-hoc analysis. A subgroup of 54 patients with biopsy-proven cardiac amyloid infiltration were compared with 41 healthy individuals to evaluate the discriminative ability of echocardiographic findings. Read More

    Systemic Light Chain Amyloidosis Mimicking Rheumatic Disorders.
    Case Rep Med 2016 29;2016:7649510. Epub 2016 Nov 29.
    Lupus Center of Excellence, Allegheny Health Network, 4800 Friendship Avenue, Suite 2600, North Tower, Pittsburgh, PA 15224, USA.
    Secondary amyloidosis can complicate chronic inflammatory autoimmune diseases. However, the clinical findings of primary amyloidosis may mimic those of primary rheumatologic disorders. We present the case of a 53-year-old woman who presented with dystrophic nail changes, dry eyes, bilateral carpal tunnel syndrome, Raynaud's phenomenon, and high titer positive nucleolar pattern antinuclear antibody. Read More

    Ectropion and Conjunctival Mass in a Patient with Primary Bilateral Conjunctival Amyloidosis.
    Case Rep Ophthalmol Med 2016 16;2016:5610753. Epub 2016 Nov 16.
    Department of Ophthalmology, American University of Beirut Medical Center, Beirut, Lebanon.
    Background. Amyloidosis is a group of disorders characterized by deposition of an extracellular protein, known as amyloid, in an abnormal fibrillar form with highly characteristic histopathologic staining properties. The clinical presentation can vary from a focal, localized lesion where amyloidosis has minor clinical consequences to extensive systemic disease that can involve any organ system of the body. Read More

    Aβ Amyloid Pathology Affects the Hearts of Patients With Alzheimer's Disease: Mind the Heart.
    J Am Coll Cardiol 2016 Dec;68(22):2395-2407
    Cardiovascular Institute, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Division of Cardiology Massachusetts General Hospital, Boston, Massachusetts. Electronic address:
    Background: Individually, heart failure (HF) and Alzheimer's disease (AD) are severe threats to population health, and their potential coexistence is an alarming prospect. In addition to sharing analogous epidemiological and genetic profiles, biochemical characteristics, and common triggers, the authors recently recognized common molecular and pathological features between the 2 conditions. Whereas cognitive impairment has been linked to HF through perfusion defects, angiopathy, and inflammation, whether patients with AD present with myocardial dysfunction, and if the 2 conditions bear a common pathogenesis as neglected siblings are unknown. Read More

    Improved Brain Expression of Anti-Amyloid β scFv by Complexation of mRNA Including a Secretion Sequence with PEG-based Block Catiomer.
    Curr Alzheimer Res 2017 ;14(3):295-302
    Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656, Japan.
    Background: The ever-increasing number of people living with Alzheimer's disease urges to develop more effective therapies. Despite considerable success, anti-Alzheimer immunotherapy still faces the challenge of intracerebral and intracellular delivery. This work introduces in situ production of anti-amyloid beta (Aβ) antibody after intracerebral injection of PEG-PAsp(DET)/mRNA polyplexes as a novel immunotherapy approach and a safer alternative compared to high systemic antibodies doses or administration of adenovirus encoding anti- Aβ antibodies. Read More

    Primary localized cutaneous amyloidosis with lichen and poikiloderma-like lesions and an excellent response to systemic acitretin.
    An Bras Dermatol 2016 Sep-Oct;91(5):661-663
    Third Affiliated Hospital, Sun Yat-sen University - Guangdong, China.
    Primary localized cutaneous amyloidosis is a skin-limited amyloidosis that does not involve internal organs. It is clinically subclassified into 3 general categories and some rare variants. However, there is considerable overlap within the classification. Read More

    Progressive refractory light chain amyloidosis and multiple myeloma patients are responsive to the addition of clarithromycin to IMiD based therapy.
    Am J Hematol 2017 02 21;92(2):131-135. Epub 2016 Nov 21.
    Department of Hematology, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
    Multiple myeloma (MM) and primary systemic light chain amyloidosis (AL) are both chronic plasma cell dyscrasias with different clinical expression but limited treatment options for relapsed refractory disease. We report the effect of the addition of clarithromycin on 31 MM and 17 AL with relapsed or refractory disease who had an insufficient response or disease progression while on an IMiD based therapy. In this high risk population, hematological response was reported in 48% of MM patients and 94% of AL patients. Read More

    [Hepatic amyloidosis as a rare differential diagnosis of progressive liver failure].
    Dtsch Med Wochenschr 2016 Sep 19;141(19):1387-9. Epub 2016 Sep 19.
    Primary systemic amyloidosis is a rare disorder resulting in extracellular deposition of insoluble fibrils in different organs. Liver involvement has been reported. Since hepatic amyloidosis often presents clinically asymptomatic without specific laboratory or imaging hallmarks, diagnosis is challenging. Read More

    Molecular basis of a novel renal amyloidosis due to N184K gelsolin variant.
    Sci Rep 2016 Sep 16;6:33463. Epub 2016 Sep 16.
    CNR Istituto di Biofisica, c/o Dipartimento di Bioscienze, Università degli Studi di Milano, 20133 Milano, Italy.
    Mutations in gelsolin are responsible for a systemic amyloidosis first described in 1969. Until recently, the disease was associated with two substitutions of the same residue, leading to the loss of the calcium binding site. Novel interest arose in 2014 when the N184K variant of the protein was identified as the etiological agent of a novel kidney-localized amyloidosis. Read More

    Localized primary amyloidosis of the breast: a case report and review of the literature.
    BMC Surg 2016 Sep 13;16(1):62. Epub 2016 Sep 13.
    Department of Breast Surgery, Shiga Medical Center for Adults, Shiga, Japan.
    Background: Primary amyloidosis of the breast is an unusual benign disease that mostly occurs in postmenopausal elderly women. Amyloidosis is the deposition of amorphous protein within tissues. Breast biopsy is necessary to make a definite diagnosis in order to avoid unnecessary surgical methods. Read More

    A Case of Primary Systemic Amyloidosis and Type 2 Diabetes Presenting with Nephrotic Syndrome and Recurrent Periorbital Purpura.
    West Indian Med J 2016 Feb 15. Epub 2016 Feb 15.
    Division of Nephrology, West China Hospital of Sichuan University, Chengdu 610041, Sichuan, China, E-mail:
    The clinical manifestations of primary systemic amyloidosis with the involvement of a variety of organs, such as the kidney, heart, peripheral nervous system, liver, and so forth, are varied, complicated and nonspecific. The mucocutaneous manifestations, sometimes as the symptom in the early stages of disease, may provide an important clue for the diagnostic suspicion. Here we described a case of primary systemic amyloidosis with the history of Type 2 diabetes mellitus (T2DM) for nine years who had recurrent periorbital purpura in the initial stage, followed by nephrotic syndrome. Read More

    Prognostic Value of Late Gadolinium Enhancement CMR in Systemic Amyloidosis.
    JACC Cardiovasc Imaging 2016 Nov 24;9(11):1267-1277. Epub 2016 Aug 24.
    Department of Radiology, University of Arkansas for Medical Sciences, Little Rock, Arkansas.
    Objectives: The aim of this study was to access the prognostic implication of late gadolinium enhancement (LGE) in patients with systemic amyloidosis undergoing cardiac magnetic resonance (CMR).

    Background: Cardiac amyloidosis confers significantly worse prognosis in patients with systemic amyloidosis. CMR imaging has emerged as an attractive noninvasive modality to diagnose cardiac involvement in patients with systemic amyloidosis. Read More

    The Prevalence and Management of Systemic Amyloidosis in Western Countries.
    Kidney Dis (Basel) 2016 Apr 25;2(1):10-9. Epub 2016 Feb 25.
    Department of Rheumatology & Clinical Immunology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
    Background: Amyloidosis has been a mystery for centuries, but research of the last decennia has clarified many of the secrets of this group of diseases. A protein-based classification of amyloidosis helps to understand problems that were part of the obsolete clinical classification in primary, secondary, and familial amyloidosis. All types of amyloid are secondary to some underlying precursor-producing process: each type is caused by a misfolded soluble precursor protein that becomes deposited as insoluble amyloid fibrils. Read More

    Nodular Cutaneous Amyloidosis at the Temple.
    Case Rep Dermatol 2016 May-Aug;8(2):193-6. Epub 2016 Jul 12.
    Department of Dermatology, University Medical Center Regensburg, Regensburg, Germany.
    A 52-year-old woman presented with a large partially yellow and erythematous tumor on her right temple. She reported that it had grown over the last 4 years. Regional lymph nodes were impalpable. Read More

    Transthyretin amyloid neuropathy has earlier neural involvement but better prognosis than primary amyloid counterpart: an answer to the paradox?
    Ann Neurol 2016 Sep 25;80(3):401-11. Epub 2016 Jul 25.
    Department of Neurology, Mayo Clinic, Rochester, MN.
    Objective: To systematically compare transthyretin with primary amyloid neuropathy to define their natural history and the underlying mechanisms for differences in phenotype and natural history.

    Methods: All patients with defined amyloid subtype and peripheral neuropathy who completed autonomic testing and electromyography at Mayo Clinic Rochester between 1993 and 2013 were included. Medical records were reviewed for time of onset of defined clinical features. Read More

    Electrophysiological Mechanisms of Bayés Syndrome: Insights from Clinical and Mouse Studies.
    Front Physiol 2016 31;7:188. Epub 2016 May 31.
    Department of Medicine and Therapeutics, The Chinese University of Hong KongHong Kong, China; Department of Epidemiology and Preventive Medicine, Monash UniversityMelbourne, VIC, Australia.
    Bayés syndrome is an under-recognized clinical condition characterized by inter-atrial block (IAB). This is defined electrocardiographically as P-wave duration > 120 ms and can be categorized into first, second and third degree IAB. It can be caused by inflammatory conditions such as systemic sclerosis and rheumatoid arthritis, abnormal protein deposition in cardiac amyloidosis, or neoplastic processes invading the inter-atrial conduction system, such as primary cardiac lymphoma. Read More

    Intensity-modulated radiotherapy for localized nasopharyngeal amyloidosis : Case report and literature review.
    Strahlenther Onkol 2016 Dec 14;192(12):944-950. Epub 2016 Jun 14.
    Cancer Center, Union Hospital, Tongji Medical College, HuaZhong University of Science and Technology, 430022, Wuhan, China.
    Background: Primary localized amyloidosis is characterized by the deposition of amyloid proteins restricted to one organ, without systemic involvement. Primary nasopharyngeal amyloidosis is an exceedingly rare condition, for which the standard treatment remains unknown. Because of its challenging anatomical position, surgery alone hardly results in complete resection of the localized amyloidosis. Read More

    Nodular Cutaneous Amyloidosis Resembling a Giant Tumor.
    Case Rep Dermatol 2016 Jan-Apr;8(1):22-5. Epub 2016 Feb 3.
    Department of Dermatology, University Medical Center Regensburg, Germany.
    A 79-year-old man presented with a large tumor on the left side of his head, which had grown over 5 years. Regional lymph nodes were impalpable and computed tomography revealed no signs of bone infiltration. Histology showed that the entire dermis was filled with amorphous eosinophilic material. Read More

    Pulmonary arterial hypertension in primary amyloidosis.
    Pulm Circ 2016 Jun;6(2):244-8
    Division of Cardiovascular Medicine, Department of Medicine, University of Utah, Salt Lake City, Utah, USA.
    Amyloidosis involves extravascular deposition of fibrillar proteins within tissues and organs. Primary light chain amyloidosis represents the most common form of systemic amyloidosis involving deposition of monoclonal immunoglobulin light chains. Although pulmonary amyloid deposition is common in primary amyloidosis, clinically significant pulmonary amyloidosis is uncommon, and elevated pulmonary artery pressures are rarely observed in the absence of other underlying etiologies for pulmonary hypertension, such as elevated filling pressures secondary to cardiac amyloid. Read More

    Curcumin: A multi-target disease-modifying agent for late-stage transthyretin amyloidosis.
    Sci Rep 2016 May 20;6:26623. Epub 2016 May 20.
    IBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto, Rua Alfredo Allen, 208, 4200 - 135 Porto, Portugal.
    Transthyretin amyloidoses encompass a variety of acquired and hereditary diseases triggered by systemic extracellular accumulation of toxic transthyretin aggregates and fibrils, particularly in the peripheral nervous system. Since transthyretin amyloidoses are typically complex progressive disorders, therapeutic approaches aiming multiple molecular targets simultaneously, might improve therapy efficacy and treatment outcome. In this study, we evaluate the protective effect of physiologically achievable doses of curcumin on the cytotoxicity induced by transthyretin oligomers in vitro by showing reduction of caspase-3 activity and the levels of endoplasmic reticulum-resident chaperone binding immunoglobulin protein. Read More

    Abdominal distension and diarrhea as the main symptoms of primary amyloidosis: A case report and literature review.
    Exp Ther Med 2016 May 19;11(5):1809-1811. Epub 2016 Feb 19.
    Department of Hepatopancreatobiliary Surgery, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, Zhejiang 323000, P.R. China.
    Amyloidosis is a systemic disease caused by the accumulation of extracellular protein into amyloid deposits. Due to the involvement of a variety of organs and tissues, the disease has no specific clinical features and a high rate of misdiagnosis. The present study describes one case of primary amyloidosis, as confirmed by biopsies of rectal and renal tissues using Congo red staining, demonstrating that abdominal distension and diarrhea were the main symptoms of disease. Read More

    Primary Systemic Amyloidosis with Unusual Dermatological Manifestations: A Rare Case Report.
    Indian J Dermatol 2016 Mar-Apr;61(2):216-8
    Department of Dermatology, Venereology and Leprology, Government Medical College, Kota, Rajasthan, India.
    Amyloidosis is a group of heterogeneous diseases characterized by pathological deposition of proteinaceous substance extracellularly in various tissues. The clinical presentation depends on the site of amyloid deposition, with predominant involvement of mesenchymal elements and cutaneous findings in 30-40% of patients in case of primary systemic amyloidosis. We present a case of idiopathic primary systemic amyloidosis presenting with an unusual finding of nodulo-ulcerative lesion over tongue along with multiple skin-colored nodules, mimicking squamous cell carcinoma of tongue with secondary cutaneous metastasis, as well as lacking the classical presentation of purpura, macroglossia, waxy papules, and plaques. Read More

    Establishing the fluorescent amyloid ligand h-FTAA for studying human tissues with systemic and localized amyloid.
    Amyloid 2016 Jun 17;23(2):98-108. Epub 2016 Mar 17.
    a IFM-Department of Chemistry , Linköping University , Linköping , Sweden .
    Rapid and accurate detection of amyloid deposits in routine surgical pathology settings are of great importance. The use of fluorescence microscopy in combination with appropriate amyloid specific dyes is very promising in this regard. Here we report that a luminescent conjugated oligothiophene, h-FTAA, rapidly and with high sensitivity and selectivity detects amyloid deposits in verified clinical samples from systemic amyloidosis patients with AA, AL and ATTR types; as well as in tissues laden with localized amyloidosis of AANF, AIAPP and ASem1 type. Read More

    Treatment of primary cutaneous amyloidosis with laser: a review of the literature.
    Lasers Med Sci 2016 Jul 16;31(5):1027-35. Epub 2016 Mar 16.
    Department of Medicine, Division of Dermatology, College of Medicine, Prince Sattam bin Abdulaziz University, Al-Kharj, Saudi Arabia.
    Primary cutaneous amyloidosis (PCA) is a condition characterized by tissue deposition of misfolded proteins. PCA can present in different forms, namely macular, lichen, and nodular amyloidosis. These lesions can be of cosmetic concern and are difficult to treat. Read More

    A Primary Cutaneous CD30-Positive T-Cell Lymphoproliferative Disorder Arising in a Patient With Multiple Myeloma and Cutaneous Amyloidosis.
    Am J Dermatopathol 2016 May;38(5):388-92
    *Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN; †Department of Dermatology, Mayo Clinic, Rochester, MN, Dr. Cohen is now affiliated with the Department of Pathology and Immunology, Baylor College of Medicine, and Department of Pathology, Michael E. DeBakey Veterans Affairs Hospital, Houston, TX (As of/After July 1, 2015); ‡Department of Laboratory Medicine and Pathology, Division of Hematopathology, Mayo Clinic, Rochester, MN; and §Departments of Laboratory Medicine and Pathology, and Dermatology, Mayo Clinic, Rochester, MN.
    CD30-positive cutaneous lymphoproliferative disorders, a group of T-cell neoplasms, including lymphomatoid papulosis (LyP) and cutaneous anaplastic large cell lymphoma, require careful clinicopathologic correlation for diagnosis. An association between LyP and the development of a second hematolymphoid malignancy has been established in the literature. LyP has also been reported with systemic amyloidosis, but no such reports have documented coexisting cutaneous amyloid deposition with LyP to our knowledge. Read More

    Multisystem diseases affecting the skin and eye.
    Clin Dermatol 2016 Mar-Apr;34(2):214-41. Epub 2015 Nov 22.
    Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA. Electronic address:
    There exist a wide variety of multisystem diseases that can affect both the eyes and skin. The skin and eyes may be the initial sites affected, leading to a new diagnosis of a systemic illness, or severe skin and eye involvement can drive treatment for patients with multisystem disease. It is important for physicians to be aware of how to recognize and diagnose these conditions, to evaluate patients for extent of disease, and to initiate appropriate therapies to combat these potentially severe diseases. Read More

    Carpal tunnel syndrome: a common initial symptom of systemic wild-type ATTR (ATTRwt) amyloidosis.
    Amyloid 2016 8;23(1):58-63. Epub 2016 Feb 8.
    a Department of Medicine (Neurology and Rheumatology) .
    Background: Systemic wild-type ATTR (ATTRwt) amyloidosis is a prevalent aging-related disorder. However, a limited number of systemic ATTRwt amyloidosis patients have been diagnosed antemortem, and therefore, the prevalence of ATTRwt is underestimated. Here, we investigated clinical findings of a series of systemic ATTRwt amyloidosis patients with antemortem diagnosis. Read More

    Sinonasal Globular Amyloidosis Simulating Malignancy: A Rare Presentation.
    Head Neck Pathol 2016 Sep 16;10(3):379-83. Epub 2016 Jan 16.
    Department of Pathology, Government Medical College, Haldwani-Nainital, Uttarakhand, India.
    Primary localized amyloidosis in the head and neck region is a rare entity. The most commonly involved organ is larynx. Primary amyloidosis localized to the sinonasal tract is extremely rare. Read More

    Fatal recurrent dermatoneuro syndrome associated with systemic AL amyloidosis.
    Clin Neuropathol 2016 Mar-Apr;35(2):72-7
    A male patient is presented with long-lasting paraproteinemia of monoclonal IgG λ, who suffered from recurrent, and until the last one, mostly reversible episodes of dermatoneuro syndrome, described exclusively in scleromyxedema. The skin biopsy revealed λ-light chain amyloid deposition instead of changes typical for scleromyxedema. Systemic AL amyloidosis was diagnosed post mortem since the patient had no clinical signs of any other organ impairment except skin and brain. Read More

    [Primary localized cutaneous nodular amyloidosis: A diagnostic and therapeutic challenge].
    Ann Dermatol Venereol 2016 Feb 24;143(2):134-8. Epub 2015 Dec 24.
    Service de dermatologie, hôpital Saint-André, CHU de Bordeaux, rue Jean-Burguet, 33076 Bordeaux, France. Electronic address:
    Background: Nodular primary localized cutaneous amyloidosis (PLCA) is a rare subtype of localized cutaneous amyloidosis in which amyloid protein is derived from immunoglobulin light chains. Follow-up for progression to systemic amyloidosis or autoimmune disease is mandatory. No consensus exists regarding treatment. Read More

    Oral purpura as the first manifestation of primary systemic amyloidosis.
    Br J Oral Maxillofac Surg 2016 Jul 18;54(6):697-9. Epub 2015 Dec 18.
    Professor of Oral Medicine, School of Dental Sciences, Newcastle University, Newcastle upon Tyne, UK. Electronic address:
    Oral blood blisters and purpura are rare features of primary systemic amyloidosis (amyloid light-chain (AL) amyloidosis). We report a case in which these unusual presentations led to a diagnosis of amyloidosis, which enabled effective treatment before organ failure. Read More

    Combined Heart and Liver Transplantation: The Cedars-Sinai Experience.
    Transplant Proc 2015 Nov;47(9):2722-6
    Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California, United States. Electronic address:
    Purpose: Combined heart-liver transplantation is an increasingly accepted treatment for select patients with heart and liver disease. Despite growing optimism, heart-liver transplantation remains an infrequent operation. We report our institutional experience with heart-liver transplantation. Read More

    1 OF 26